European Respiratory Society Monograph, Vol. 38. 2006
ISBN: 978-1-904097-84-6
DOI: 10.1183/1025448x.erm3806
Since the 1970s, therapeutic nihilism has moved towards a more optimistic attitude regarding therapeutic alternatives in COPD. Research focused on inflammatory and physiological mechanisms has substantially increased during the last 10 years. This has led to an increased understanding of the pathophysiology of the disease, which has resulted in improved treatment. Thus, in parallel to smoking-cessation programmes, other treatment modalities have been shown to be successful. Physiotherapy and pharmacotherapy have been extensively studied and the knowledge regarding what these therapeutic approaches can offer is constantly growing. The importance of nutritional aspects and adjustment in daily life activities have made dieticians and occupational therapists important members of the treatment team. Vaccination programmes, treatment of infections and lung volume reduction surgery are other therapeutic alternatives that have contributed to the improved care of COPD patients.
Preface K. Larsson Eur Respir Mon; 2006: 38: viii |  |
Introduction N.M. Siafakas Eur Respir Mon; 2006: 38: ix |  |
Definition and differential diagnosis of chronic obstructive pulmonary disease N.M. Siafakas Eur Respir Mon; 2006: 38: 1–6 |  |
Chronic obstructive pulmonary disease: symptoms and signs P.M.A. Calverley, D. Georgopoulos Eur Respir Mon; 2006: 38: 7–23 |  |
Chronic obstructive pulmonary disease: investigations and assessment of severity G.J. Gibson, W. MacNee Eur Respir Mon; 2006: 38: 24–40 |  |
Epidemiology of chronic obstructive pulmonary disease I. Annesi-Maesano Eur Respir Mon; 2006: 38: 41–70 |  |
The natural history of chronic obstructive pulmonary disease D.S. Postma, H.M. Boezen Eur Respir Mon; 2006: 38: 71–83 |  |
Genetic susceptibility to chronic obstructive pulmonary disease E.G. Tzortzaki, N.M. Siafakas Eur Respir Mon; 2006: 38: 84–99 |  |
Oxidative stress and chronic obstructive pulmonary disease W. MacNee Eur Respir Mon; 2006: 38: 100–129 |  |
Cells and mediators of chronic obstructive pulmonary disease P.J. Barnes, M.G. Cosio Eur Respir Mon; 2006: 38: 130–158 |  |
Pathology of chronic obstructive pulmonary disease M. Saetta, G. Turato, W. Timens, P.K. Jeffery Eur Respir Mon; 2006: 38: 159–176 |  |
Pathophysiology of chronic obstructive pulmonary disease R. Rodriguez-Roisin, W. MacNee Eur Respir Mon; 2006: 38: 177–200 |  |
Respiratory and skeletal muscles in chronic obstructive pulmonary disease G. Gayan-Ramirez, N. Koulouris, J. Roca, M. Decramer Eur Respir Mon; 2006: 38: 201–223 |  |
Systemic effects of chronic obstructive pulmonary disease E.F.M. Wouters, A.M.W.J. Schols, B. Celli Eur Respir Mon; 2006: 38: 224–241 |  |
Smoking cessation and prevention C. Gratziou, P. Tønnesen Eur Respir Mon; 2006: 38: 242–257 |  |
Overall management of stable chronic obstructive pulmonary disease N.M. Siafakas, B. Celli Eur Respir Mon; 2006: 38: 258–265 |  |
Bronchodilators in chronic obstructive pulmonary disease S.I. Rennard, P.M.A. Calverley Eur Respir Mon; 2006: 38: 266–280 |  |
Oral or inhaled corticosteroids for patients with chronic obstructive pulmonary disease S. Burge Eur Respir Mon; 2006: 38: 281–295 |  |
Use of antibiotics, antioxidants, mucolytics and vaccines in the therapy of chronic obstructive pulmonary disease H. Lode, L. Larsson, J. Rollof
|  |
Oxygen therapy in chronic obstructive pulmonary disease I. Mitrouska, N. Tzanakis, N.M. Siafakas Eur Respir Mon; 2006: 38: 302–312 |  |
Treatment of pulmonary hypertension in chronic obstructive pulmonary disease E. Weitzenblum, M. Delcroix Eur Respir Mon; 2006: 38: 313–324 |  |
Sleep in chronic obstructive disease W.T. McNicholas Eur Respir Mon; 2006: 38: 325–336 |  |
Rehabilitation in chronic obstructive pulmonary disease T. Troosters, C.F. Donner, A.M.W.J. Schols, M. Decramer Eur Respir Mon; 2006: 38: 337–358 |  |
Surgical treatment of chronic obstructive pulmonary disease E.W. Russi, S. Imfeld, A. Boehler, W. Weder Eur Respir Mon; 2006: 38: 359–374 |  |
Quality of life in patients with chronic obstructive pulmonary disease P.W. Jones, P.J. Wijkstra Eur Respir Mon; 2006: 38: 375–386 |  |
Management of acute exacerbation of chronic obstructive pulmonary disease N.M. Siafakas, J.A. Wedzicha Eur Respir Mon; 2006: 38: 387–400 |  |
Ventilator support in chronic obstructive pulmonary disease: invasive and noninvasive S. Khirani, D. Georgopoulos, A. Rossi, J. Moxham Eur Respir Mon; 2006: 38: 401–429 |  |
Management of end-stage chronic obstructive pulmonary disease M. Klimathianaki, I. Mitrouska, D. Georgopoulos Eur Respir Mon; 2006: 38: 430–450 |  |
Air travel and anaesthesia in chronic obstructive pulmonary disease N. Tzanakis, E. Kosmas Eur Respir Mon; 2006: 38: 451–462 |  |
Socioeconomic burden of chronic obstructive pulmonary disease J. Vestbo Eur Respir Mon; 2006: 38: 463–469 |  |
Future research in chronic obstructive pulmonary disease N.M. Siafakas, P.J. Barnes Eur Respir Mon; 2006: 38: 470–475 |  |